Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-11 | Krystal Biotech, Inc. | Krishnan Suma
(President, R&D) |
S | Common Stock | D | 50000 | $167.99 - $174.13 | $8,547,710 |
| 2024-03-11 | Krystal Biotech, Inc. | Krishnan Krish S
(President and CEO) |
S | Common Stock | D | 50000 | $167.99 - $174.13 | $8,547,710 |
| 2024-02-28 | Krystal Biotech, Inc. | ROMANO KATHRYN
(Chief Accounting Officer) |
S | Common Stock | D | 5000 | $162.71 - $172.23 | $829,413 |
| 2024-02-28 | Krystal Biotech, Inc. | ROMANO KATHRYN
(Chief Accounting Officer) |
M | Common Stock | A | 10000 | $63.55 - $63.55 | $317,747 |
| 2024-02-28 | Krystal Biotech, Inc. | ROMANO KATHRYN
(Chief Accounting Officer) |
F | Common Stock | D | 2314 | $163.08 - $163.08 | $377,367 |
| 2024-02-28 | Krystal Biotech, Inc. | ROMANO KATHRYN
(Chief Accounting Officer) |
S | Common Stock | D | 7500 | $162.73 - $171.66 | $1,245,376 |
| 2024-02-28 | Krystal Biotech, Inc. | ROMANO KATHRYN
(Chief Accounting Officer) |
M | Common Stock | A | 7500 | $63.55 - $63.55 | $476,621 |
| 2024-02-28 | Krystal Biotech, Inc. | Krishnan Suma
(President, R&D) |
M | Common Stock | A | 20000 | $0.00 - $0.00 | $0 |
| 2024-02-28 | Krystal Biotech, Inc. | Krishnan Suma
(President, R&D) |
F | Common Stock | D | 9256 | $163.08 - $163.08 | $1,509,467 |
| 2024-02-28 | Krystal Biotech, Inc. | Krishnan Krish S
(President and CEO) |
M | Common Stock | A | 20000 | $0.00 - $0.00 | $0 |
| 2024-02-28 | Krystal Biotech, Inc. | Krishnan Krish S
(President and CEO) |
F | Common Stock | D | 9256 | $163.08 - $163.08 | $1,509,467 |
| 2024-02-26 | Krystal Biotech, Inc. | Krishnan Suma
(President, R&D) |
F | Common Stock | D | 2353 | $157.00 - $157.00 | $369,421 |
| 2024-02-26 | Krystal Biotech, Inc. | Krishnan Krish S
(President and CEO) |
F | Common Stock | D | 3791 | $157.00 - $157.00 | $595,187 |
| 2024-02-26 | Krystal Biotech, Inc. | ROMANO KATHRYN
(Chief Accounting Officer) |
S | Common Stock | D | 8087 | $135.00 - $140.00 | $1,107,180 |
| 2024-02-26 | Krystal Biotech, Inc. | ROMANO KATHRYN
(Chief Accounting Officer) |
M | Common Stock | A | 10000 | $52.26 - $52.26 | $522,599 |
| 2024-02-26 | Krystal Biotech, Inc. | ROMANO KATHRYN
(Chief Accounting Officer) |
F | Common Stock | D | 1533 | $157.00 - $157.00 | $240,681 |
| 2024-01-22 | Krystal Biotech, Inc. | Romano Kathryn
(Chief Accounting Officer) |
S | Common Stock | D | 2500 | $130.00 - $130.00 | $325,000 |
| 2024-01-22 | Krystal Biotech, Inc. | Romano Kathryn
(Chief Accounting Officer) |
M | Common Stock | A | 2500 | $52.26 - $52.26 | $130,650 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |